Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma

CHIA-LING CHANGMIN-SHU HSIEHJIN-YUAN SHIHLee, Yi-HsuanYi-HsuanLeeWEI-YU LIAOCHIA-LIN HSUCHING-YAO YANGKUAN-YU CHENJIH-HSIANG LEECHAO-CHI HOTZU-HSIU TSAICHIH-HSIN YANGCHONG-JEN YU2022-12-202022-12-2020221758-8340https://scholars.lib.ntu.edu.tw/handle/123456789/626634A definitive diagnosis of pulmonary sarcomatoid carcinoma cannot be made with small biopsies. In clinical practice, a diagnosis of advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma (NSCLCsg), or possible sarcomatoid carcinoma, is acceptable. Therefore, we aimed to investigate the treatment patterns and outcomes of advanced NSCLCsg.enimmune checkpoint inhibitor; non-small-cell lung cancer with spindle cell and/or giant cell carcinoma; overall survival; programmed death ligand-1; pulmonary sarcomatoid carcinoma[SDGs]SDG3Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinomajournal article10.1177/17588359221133889363247322-s2.0-85140822248WOS:000878304200001https://api.elsevier.com/content/abstract/scopus_id/85140822248